Trilaciclib is the first FDA-approved therapy in its class to help protect bone marrow cells from damage caused by chemotherapy.
Florida Cancer Specialists & Research Institute
Advertisement
Articles by Florida Cancer Specialists & Research Institute
Physicians can make an exact diagnosis and prognosis and plan treatment that targets a specific tumor with great precision.
Are smoothies as good as actually eating those fruits and vegetables?
Swift treatment can improve cancer survival rates.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
4
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
5
